kabutan

WAKAMOTO PHARMACEUTICAL CO.,LTD., First Half Ordinary Profit Loss Narrows, July-September Ordinary Profit Loss Narrows

Wed Nov 6, 2024 3:30 pm JST Earnings

4512 WAKAMOTO PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

WAKAMOTO PHARMACEUTICAL CO.,LTD. <4512> [TSE-S] announced its financial results after the market closed on November 6th (15:30). The ordinary loss (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2025 (April to September) was a reduced loss of 256 million yen (compared to a loss of 319 million yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the ordinary loss improved to a deficit of loss of 192 million yen (compared to a loss of 291 million yen in the same period last year). The operating profit/loss margin drastically improved from -15.4% in the same period last year to -9.7%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 4,019 -85 -27 -21 -0.6 Nov 7, 2022 J-GAAP
Apr - Sep, 2023 3,618 -328 -319 -222 -6.4 Nov 6, 2023 J-GAAP
Apr - Sep, 2024 3,811 -276 -256 -141 -4.1 Nov 6, 2024 J-GAAP
YoY +5.3% +15.9% +19.7% +36.5% +36.4%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance May 15, 2024 J-GAAP
Apr - Sep, 2024 Results 3,811 -276 -256 -141 -4.1 0 Nov 6, 2024 J-GAAP
Revision Rate

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 4,120 133 158 330 9.6 3 May 15, 2024 J-GAAP
Oct - Mar, 2024 Guidance May 15, 2024 J-GAAP
YoY

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 8,660 141 242 138 4.0 3 May 15, 2023 J-GAAP
Mar, 2024 7,738 -195 -161 108 3.1 3 May 15, 2024 J-GAAP
Mar, 2025 Guidance May 15, 2024 J-GAAP
YoY

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 1,758 -271 -291 -322 -9.3 -15.4 Nov 6, 2023 J-GAAP
Oct - Dec, 2023 1,968 69 94 17 0.5 3.5 Feb 5, 2024 J-GAAP
Jan - Mar, 2024 2,152 64 64 313 9.1 3.0 May 15, 2024 J-GAAP
Apr - Jun, 2024 1,884 -89 -64 -11 -0.3 -4.7 Aug 2, 2024 J-GAAP
Jul - Sep, 2024 1,927 -187 -192 -130 -3.8 -9.7 Nov 6, 2024 J-GAAP
YoY +9.6% +31.0% +34.0% +59.6% +59.6%

Related Articles